Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071559
Filing Date
2025-05-14
Accepted
2025-05-14 16:50:18
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20250331.htm   iXBRL 10-Q 1790391
2 EX-31.1 cvsi-ex31_1.htm EX-31.1 15537
3 EX-31.2 cvsi-ex31_2.htm EX-31.2 15242
4 EX-32.1 cvsi-ex32_1.htm EX-32.1 7123
5 EX-32.2 cvsi-ex32_2.htm EX-32.2 7111
  Complete submission text file 0000950170-25-071559.txt   8036034

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20250331.xsd EX-101.SCH 1145913
78 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20250331_htm.xml XML 1352827
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 25946695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)